Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CardioMEMS HF System Coverage With Evidence Development Study

NCT: NCT06779552 · RECRUITING

NCT IDNCT06779552
StatusRECRUITING
Start Date2025-02-07
Completion2032-03

Brief Summary

The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.

Frequently Asked Questions

What is CardioMEMS HF System Coverage With Evidence Development Study?

CardioMEMS HF System Coverage With Evidence Development Study is a clinical trial registered under NCT06779552. Current status: RECRUITING.

What is the status of NCT06779552?

The current status of NCT06779552 (CardioMEMS HF System Coverage With Evidence Development Study) is: RECRUITING.

When did CardioMEMS HF System Coverage With Evidence Development Study start?

CardioMEMS HF System Coverage With Evidence Development Study started on 2025-02-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑